Egetis Therapeutics AB (publ) (STO:EGTX)

Chimerix Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	272.8	351	303.3	127.7	144	287.85
Cash & Short-Term Investments	272.8	351	303.3	127.7	144	287.85
Cash Growth	8.38%	15.73%	137.51%	-11.32%	-49.97%	12.84%
Accounts Receivable	19.7	15.5	28.2	3.8	3.5	3.88
Other Receivables	8.6	8.1	8.4	6.7	3.3	3.58
Receivables	28.3	23.6	36.6	10.5	6.8	7.46
Inventory	0.7	1	0.7	0.6	0.7	3.14
Prepaid Expenses	4.3	4.1	4.4	8.2	1.3	1.42
Other Current Assets	-	0.4	0.9	0.4	0.1	0
Total Current Assets	306.1	380.1	345.9	147.4	152.9	299.87
Property, Plant & Equipment	10.6	2.6	4.4	2.7	4.3	4.74
Long-Term Investments	0.8	0.8	0.8	0.8	0.8	-
Other Intangible Assets	3	3.2	4.3	5.4	6.5	7.57
Long-Term Deferred Tax Assets	2.1	0.6	-	-	-	-
Long-Term Deferred Charges	401.4	404.8	404.8	404.8	404.8	404.82
Other Long-Term Assets	0.1	0.2	-	-	-	-
Total Assets	724.1	792.3	760.2	561.1	569.3	717
Accounts Payable	19.7	25.7	28.7	20	4.6	15.61
Accrued Expenses	140.1	131	47.2	12.7	5.3	3.51
Current Portion of Long-Term Debt	29.2	30.1	5.2	-	-	-
Current Portion of Leases	-	2.5	2.2	1.6	1.5	1.14
Current Income Taxes Payable	-	0.2	0.1	-	-	-
Other Current Liabilities	10.7	14.7	20.5	15.1	27.8	49.88
Total Current Liabilities	199.7	204.2	103.9	49.4	39.2	70.14
Long-Term Debt	69.5	84.1	103.4	-	-	-
Long-Term Leases	7.8	0.4	2.2	1.1	2.7	3.53
Long-Term Deferred Tax Liabilities	2.1	0.5	-	-	-	-
Other Long-Term Liabilities	11.7	10.2	5.1	4.4	0.4	12.61
Total Liabilities	290.8	299.4	214.6	54.9	42.3	86.28
Common Stock	20.4	20.4	15.4	11.3	8.7	8.69
Additional Paid-In Capital	2,058	2,058	1,780	1,428	1,263	1,263
Retained Earnings	-1,673	-1,610	-1,267	-939.6	-745.8	-641.25
Comprehensive Income & Other	28.4	24.9	16.7	6.1	1.3	0.45
Shareholders' Equity	433.3	492.9	545.6	506.2	527	630.72
Total Liabilities & Equity	724.1	792.3	760.2	561.1	569.3	717
Total Debt	106.5	117.1	113	2.7	4.2	4.67
Net Cash (Debt)	166.3	233.9	190.3	125	139.8	283.18
Net Cash Growth	25.51%	22.91%	52.24%	-10.59%	-50.63%	11.06%
Net Cash Per Share	0.51	0.75	0.73	0.64	0.78	4.20
Filing Date Shares Outstanding	359.24	359.24	292.57	214.59	165.07	165.07
Total Common Shares Outstanding	359.24	359.24	292.57	214.59	165.07	165.07
Working Capital	106.4	175.9	242	98	113.7	229.73
Book Value Per Share	1.21	1.37	1.86	2.36	3.19	3.82
Tangible Book Value	430.3	489.7	541.3	500.8	520.5	623.15
Tangible Book Value Per Share	1.20	1.36	1.85	2.33	3.15	3.78
Machinery	-	0.1	0.3	0.2	0.3	0.08

Source: S&P Global Market Intelligence. Standard template. Financial Sources.